This brings their total sales since the beginning of the financial year to 30 transactions, amounting to €239 million, with a weighted average net initial yield of 4.8%.
According to the company, the proceeds will be used to reduce debt associated with the financing of a €600 million portfolio of private hospitals, acquired in August 2024, with a yield of 5.9%. This is part of Assura’s broader debt reduction strategy.
It is also worth noting that last month, the investment group KKR made a series of offers for Assura, offering a 28% premium based on current market transactions. However, the board rejected these offers, triggering mixed reactions from shareholders.
